Pinkawa M - Search Results

1

Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.

Wolf F, Sedlmayer F, Aebersold D, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Ghadjar P, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Schmidt-Hegemann NS, Zamboglou C, Zips D, Wiegel T. Wolf F, et al. Among authors: pinkawa m. Strahlenther Onkol. 2021 Feb;197(2):89-96. doi: 10.1007/s00066-020-01723-8. Epub 2020 Dec 10. Strahlenther Onkol. 2021. PMID: 33301049 Free PMC article. Review.

2

Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.

Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P. Bamias A, et al. Among authors: pinkawa m. Eur Urol. 2023 Oct;84(4):381-389. doi: 10.1016/j.eururo.2023.05.005. Epub 2023 May 20. Eur Urol. 2023. PMID: 37217391

3

Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer.

Pinkawa M, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2006 Sep;182(9):525-30. doi: 10.1007/s00066-006-1529-5. Strahlenther Onkol. 2006. PMID: 16944374

4

Pinkawa M, Fischedick K, Piroth MD, Gagel B, Borchers H, Jakse G, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2006 Nov;182(11):660-5. doi: 10.1007/s00066-006-1530-z. Strahlenther Onkol. 2006. PMID: 17072524

5

Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy).

Pinkawa M, Siluschek J, Gagel B, Piroth MD, Demirel C, Asadpour B, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2007 Jan;183(1):23-9. doi: 10.1007/s00066-007-1588-2. Strahlenther Onkol. 2007. PMID: 17225942

6

Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis.

Pinkawa M, Piroth MD, Asadpour B, Gagel B, Fischedick K, Siluschek J, Kehl M, Krenkel B, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2009 Feb;185(2):101-8. doi: 10.1007/s00066-009-1894-y. Epub 2009 Feb 25. Strahlenther Onkol. 2009. PMID: 19240996 Clinical Trial.

7

Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.

Pinkawa M, Piroth MD, Fischedick K, Holy R, Klotz J, Nussen S, Krenkel B, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2009 Nov;185(11):724-30. doi: 10.1007/s00066-009-2008-6. Epub 2009 Nov 10. Strahlenther Onkol. 2009. PMID: 19899005

8

Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.

Pinkawa M, Holy R, Piroth MD, Klotz J, Nussen S, Krohn T, Mottaghy FM, Weibrecht M, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2010 Nov;186(11):600-6. doi: 10.1007/s00066-010-2122-5. Epub 2010 Sep 30. Strahlenther Onkol. 2010. PMID: 20936457

9

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

Pinkawa M, Piroth MD, Holy R, Djukic V, Klotz J, Krenkel B, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2011 Aug;187(8):479-84. doi: 10.1007/s00066-011-2249-z. Epub 2011 Jul 25. Strahlenther Onkol. 2011. PMID: 21789739

10

Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis.

Pinkawa M, Piroth MD, Holy R, Escobar-Corral N, Caffaro M, Djukic V, Klotz J, Eble MJ. Pinkawa M, et al. Strahlenther Onkol. 2012 Oct;188(10):917-25. doi: 10.1007/s00066-012-0172-6. Epub 2012 Aug 31. Strahlenther Onkol. 2012. PMID: 22933033 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters